当前位置: X-MOL 学术Nat. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A ‘mix and match’ approach to SARS-CoV-2 vaccination
Nature Medicine ( IF 82.9 ) Pub Date : 2021-07-26 , DOI: 10.1038/s41591-021-01463-x
Meagan E Deming 1 , Kirsten E Lyke 1
Affiliation  

Heterologous dosing with the adenovirus-based ChAdOx1 (AstraZeneca) vaccine followed by an mRNA vaccine induced stronger immune responses than did the homologous ChAdOx1 vaccine series, according to recent immunogenicity studies.

中文翻译:

SARS-CoV-2 疫苗接种的“混合搭配”方法

根据最近的免疫原性研究,与同源 ChAdOx1 疫苗系列相比,异源给药基于腺病毒的 ChAdOx1(阿斯利康)疫苗,然后接种 mRNA 疫苗,可诱导更强的免疫反应。
更新日期:2021-07-26
down
wechat
bug